AMI Tone Up | Clinical Dermal Bio-Revitalizer
Medical-grade skin booster engineered for targeted hyperpigmentation correction and dermal matrix reconstruction. Formulated with high-density Sodium-DNA and plant-derived nanoscale exosomes for professional aesthetic administration.
Polynucleotides (PN)
Concentration: 2.5 mg/ml
Molecular Weight: 1,500 kDa – 2,500 kDa
Purified DNA fragments extracted from salmon germ cells. Stimulates A2A receptors, triggering immediate fibroblast proliferation and accelerating Type I and Type III collagen synthesis for dermal thickening.
Vegan Exosomes
Particle Size: 30nm – 150nm
Source: Centella Asiatica Extracellular Vesicles
Nanoscale biological lipid vesicles optimizing intercellular communication. Acts as a targeted delivery vector, bypassing the stratum corneum barrier to deliver active mRNA and growth factors directly to damaged cells.
Inhibitor Complex
Tranexamic Acid: Blocks plasminogen binding, inhibiting UV-induced melanogenesis.
Niacinamide (5%): Prevents melanosome transfer to keratinocytes.
Glutathione: Neutralizes free radicals and converts eumelanin to pheomelanin for systemic tissue brightening.
CLINICAL EFFICACY METRICS (IN-VIVO DATA)
+34%Dermal Density
-22%Melanin Index
+48%Fibroblast Activity
TECHNICAL SPECIFICATIONS
Packaging: 5ml x 6 Vials / Box
Formulation: Sterile, clear, apirogenic aqueous solution
pH Level: 6.8 – 7.5
Osmolarity: 270 – 300 mOsm/kg
Storage: 2°C to 25°C. Avoid direct sunlight. Do not freeze.
CLINICAL INJECTION PROTOCOL
Target Layer: Mid-to-deep dermis
Technique: Point-by-point micro-papule or retrograde linear threading
Equipment: 30G or 32G needle (4mm or 13mm)
Dosage per Point: 0.05ml – 0.1ml
Standard Regimen: 3-4 initial sessions spaced 14-21 days apart. Maintenance session every 3-4 months.
STRICT MEDICAL DISCLAIMER
Professional Use Only: AMI Tone Up is a Class III medical device equivalent. Sales and administration are strictly restricted to licensed medical practitioners, dermatologists, and certified aesthetic professionals.
Contraindications: Do not administer to patients with known hypersensitivity to fish-derived DNA, active cutaneous autoimmune diseases, localized infections (acne, herpes), or pregnant/lactating individuals.
Compliance: Practitioners must perform comprehensive patient anamnesis and obtain informed consent prior to intervention. Strictly prohibit self-administration.

Reviews
There are no reviews yet.